Syed Shujait Ali
Orcid: 0000-0002-6277-2335Affiliations:
- University of Swat, Pakistan
According to our database1,
Syed Shujait Ali
authored at least 11 papers
between 2021 and 2024.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2024
Using a dual immunoinformatics and bioinformatics approach to design a novel and effective multi-epitope vaccine against human torovirus disease.
Comput. Biol. Chem., 2024
2022
Screening of immune epitope in the proteome of the Dabie bandavirus, SFTS, to design a protein-specific and proteome-wide vaccine for immune response instigation using an immunoinformatics approaches.
Comput. Biol. Medicine, 2022
Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches.
Comput. Biol. Medicine, 2022
Evaluation and identification of essential therapeutic proteins and vaccinomics approach towards multi-epitopes vaccine designing against <i>Legionella pneumophila</i> for immune response instigation.
Comput. Biol. Medicine, 2022
Subtractive proteomics assisted therapeutic targets mining and designing ensemble vaccine against <i>Candida auris</i> for immune response induction.
Comput. Biol. Medicine, 2022
Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study.
Comput. Biol. Medicine, 2022
2021
Genome-wide screening of vaccine targets prioritization and reverse vaccinology aided design of peptides vaccine to enforce humoral immune response against <i>Campylobacter jejuni</i>.
Comput. Biol. Medicine, 2021
Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor.
Comput. Biol. Medicine, 2021
Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through <i>in silico</i> cloning and immune simulation.
Comput. Biol. Medicine, 2021
Comput. Biol. Medicine, 2021
Database J. Biol. Databases Curation, 2021